Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Postoperative Behavioral Changes in Children
NCT06579937Phase 4Recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Sep 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in Postoperative behavioral changes, emergence delirium (ED), sponsored by Fujian Provincial Hospital. Started Sep 2024; status: recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative behavioral changesemergence delirium (ED)
Beyond the preview
Go deeper on NCT06579937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06579937.